Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27,549
Closed -$7.62M 1209
2022
Q4
$7.63M Buy
27,549
+634
+2% +$179K 0.78% 24
2022
Q3
$7.19M Buy
26,915
+9,814
+57% +$2.08M 0.48% 44
2022
Q2
$3.49M Buy
17,101
+3,384
+25% +$692K 0.17% 113
2022
Q1
$2.89M Sell
13,717
-6,096
-31% -$1.33M 0.12% 154
2021
Q4
$4.75M Sell
19,813
-27,672
-58% -$7.12M 0.13% 139
2021
Q3
$13.4M Buy
47,485
+9,484
+25% +$3.11M 0.44% 34
2021
Q2
$13.2M Buy
38,001
+16,084
+73% +$4.87M 0.41% 44
2021
Q1
$6.13M Sell
21,917
-41
-0.2% -$11.1K 0.33% 55
2020
Q4
$5.38M Buy
+21,958
New +$5.66M 0.16% 117
2019
Q4
Sell
-36,210
Closed -$10M 1242
2019
Q3
$8.43M Buy
+36,210
New +$8.43M 0.69% 30
2017
Q2
Sell
-13,755
Closed -$3.64M 947
2017
Q1
$3.76M Buy
+13,755
New +$3.89M 0.23% 91
2016
Q4
Sell
-68,532
Closed -$20.3M 992
2016
Q3
$21.5M Buy
+68,532
New +$20.3M 0.76% 13
2016
Q2
Sell
-23,940
Closed -$6.31M 904
2016
Q1
$6.23M Sell
23,940
-74,535
-76% -$19.7M 0.45% 52
2015
Q4
$30.2M Buy
+98,475
New +$28.3M 1.46% 12
2015
Q2
Sell
-11,198
Closed -$4.49M 990
2015
Q1
$4.73M Sell
11,198
-38,700
-78% -$15.3M 0.32% 65
2014
Q4
$16.9M Buy
49,898
+2,532
+5% +$819K 0.63% 34
2014
Q3
$15.7M Buy
+47,366
New +$15.6M 0.62% 34
2014
Q2
Sell
-12,855
Closed -$3.87M 946
2014
Q1
$3.93M Buy
+12,855
New +$4.08M 0.18% 107

Other funds holding BIIB

HAP Trading's BIIB Position: Q1 2023 in Review

HAP Trading sold out of Biogen (BIIB) in Q1 2023, closing a stake of 27,549 shares — an estimated $7.62M sold.

HAP Trading first reported a position in BIIB in Q1 2014 and held it in 18 quarters. The position peaked at $30.2M in Q4 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

  • HAP Trading reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 27,549 Biogen shares in Q1 2023, an estimated $7.62M.
  • HAP Trading first reported a position in Biogen in Q1 2014 and held it in 18 quarters.
  • HAP Trading's Biogen position peaked at $30.2M in Q4 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.